Effects of anti-VEGF treatment duration on treatment efficacy
This slide deck presents data from preclinical models showing continuous VEGF suppression with anti-VEGF.
Browse & Search
Filter options
Latest Resources
-
Controlling angiogenesis to control tumour growth
Avastin precisely targets VEGF to inhibit angiogenesis for continuous tumour control
-
Expert perspectives in CRC
Impact of Avastin in CRC (Prof Eric van Cutsem)
-
Angiogenesis, VEGF and the MoA of Avastin
Precise VEGF inhibition with Avastin is a proven anti-tumour strategy
-
Expert perspective
Targeting angiogenesis (Prof Joaquin Bellmunt)
-
Expert perspectives in NSCLC
Avastin in a lung cancer patient (Prof Jürgen Wolf)
-
Expert perspective
Importance of prolonging life (Prof Manuela Schmidinger)